{"id":"NCT00689117","sponsor":"Stiefel, a GSK Company","briefTitle":"A Clinical Study to Evaluate the Safety and Effectiveness of an Investigational Product Called CT Gel","officialTitle":"A Phase 3 Multicenter, Randomized, Double-Blind, Active And Vehicle-Controlled Study Of The Safety And Efficacy Of CT Gel in Subjects With Acne Vulgaris","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2008-04","primaryCompletion":"2009-04","completion":"2009-05","firstPosted":"2008-06-03","resultsPosted":"2010-12-02","lastUpdate":"2017-05-30"},"enrollment":1649,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"QUADRUPLE","primaryPurpose":"TREATMENT"},"conditions":["Acne Vulgaris","Acne"],"interventions":[{"type":"DRUG","name":"CT Gel","otherNames":[]},{"type":"DRUG","name":"Clindamycin Gel (clindamycin )","otherNames":[]},{"type":"DRUG","name":"Tretinoin Gel (tretinoin)","otherNames":[]},{"type":"DRUG","name":"Vehicle Gel","otherNames":[]}],"arms":[{"label":"1","type":"EXPERIMENTAL"},{"label":"2","type":"ACTIVE_COMPARATOR"},{"label":"3","type":"ACTIVE_COMPARATOR"},{"label":"4","type":"PLACEBO_COMPARATOR"}],"summary":"The purpose of this study is to demonstrate the safety and effectiveness of CT Gel in subjects with acne vulgaris. The hypothesis is that CT Gel is superior to Clindamycin Gel, Tretinoin Gel and Vehicle Gel for the treatment of acne vulgaris.","primaryOutcome":{"measure":"Absolute Change From Baseline in Lesion Counts (Total, Inflammatory, and Non-inflammatory) at Week 12 (End of Study)","timeFrame":"Baseline, Week 12","effectByArm":[{"arm":"CT Gel","deltaMin":-15.5,"sd":10.33},{"arm":"Clindamycin Gel","deltaMin":-14.5,"sd":9.37},{"arm":"Tretinoin Gel","deltaMin":-13.9,"sd":11.05},{"arm":"Vehicle Gel","deltaMin":-11.1,"sd":11.7}],"pValues":[{"comp":"OG000 vs OG001","p":"0.063"},{"comp":"OG000 vs OG002","p":"0.003"},{"comp":"OG000 vs OG003","p":"<0.001"},{"comp":"OG000 vs OG001","p":"0.004"},{"comp":"OG000 vs OG002","p":"0.550"},{"comp":"OG000 vs OG003","p":"<0.001"},{"comp":"OG000 vs OG001","p":"<0.001"},{"comp":"OG000 vs OG002","p":"0.016"},{"comp":"OG000 vs OG003","p":"<0.001"}]},"eligibility":{"minAge":"12 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":2,"exclusionCount":18},"locations":{"siteCount":32,"countries":["United States","Belize","Canada"]},"refs":{"pmids":[],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":1,"n":476},"commonTop":["Nasopharyngitis"]}}